68ga-dotatate (DrugBank: 68Ga-DOTATATE, Dotatate)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 84 | サルコイドーシス | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03549598 (ClinicalTrials.gov) | July 20, 2018 | 25/5/2018 | d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis | d68Ga-DOTATATE PET/CT Assessment of Cardiac Sarcoidosis | Cardiac Sarcoidosis | Drug: 68Ga-DOTATATE PET/CT;Drug: 18FDG PET/CT scan;Drug: 13NH3 PET/CT scan | Mayo Clinic | NULL | Completed | 18 Years | N/A | All | 15 | Phase 4 | United States |